Current Report Filing (8-k)
19 6월 2015 - 4:05AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
June 10, 2015
Date of Report (Date of earliest event reported)
IMMAGE BIOTHERAPEUTICS CORP.
|
(Exact name of registrant as specified in its charter)
|
Nevada
|
|
333-183797
|
|
68-0682040
|
(State or other jurisdiction of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
1255 W. Rio Salado Parkway
Suite 215
Tempe, AZ
|
|
85281
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(480) 830-2700
Registrant’s telephone number, including area code
EPICURE CHARCOAL INC.
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEM 5.01 CHANGES IN CONTROL OF REGISTRANT
On May 21, 2015, Epicure Charcoal Inc., a Nevada corporation (the “Company”) filed Articles of Merger with the Nevada SOS whereby it entered into a statutory merger with its wholly-owned subsidiary, Immage Biotherapeutics Corp. pursuant to Nevada Revised Statutes 92A.200 et. seq. The effect of such merger is that the Company was the surviving entity and changed its name to “Immage Biotherapeutics Corp.”
On May 21, 2015, the Company filed an Issuer Company-Related Action Notification Form with FINRA requesting that the aforementioned name change be effected in the market. The Company also requested that its ticker symbol be changed to “IMMG”.
On June 10, 2015, FINRA effected the Company’s name change and ticker symbol change in the market.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
IMMAGE BIOTHERAPUETICS CORP.
|
|
|
|
|
|
Date: June 18, 2015 |
By: |
/s/ Zhi Cong Mou |
|
|
Name: |
Zhi Cong Mou |
|
|
Title: |
President |
|
|
|
|
|
3
Immage Biotherapeutics (CE) (USOTC:IMMG)
과거 데이터 주식 차트
부터 8월(8) 2024 으로 9월(9) 2024
Immage Biotherapeutics (CE) (USOTC:IMMG)
과거 데이터 주식 차트
부터 9월(9) 2023 으로 9월(9) 2024
Immage Biotherapeutics Corporation (CE) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Immage Biotherapeutics Corp. News Articles